Danaher Corp.
DHR
Get informed when a big investor buys or sells
+ FollowEarnings Call Q2 2026
July 21, 2026 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
7.3% downsideOvervalued by 7.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $134.62 Billion |
|---|---|
| Enterprise Value | $156.83 Billion |
| Dividend Yield | $1.44 (0.75%) |
| Earnings per Share | $5.07 |
| Beta | 0.82 |
| Outstanding Shares | 705,300,000 |
Return
| Return on Equity | 7.61% |
|---|---|
| Return on Assets | 4.33% |
| Return on Invested Capital | 5.98% |
Valuation & Multiples
| P/E Ratio | 33.89 |
|---|---|
| PEG | 59.72 |
| Price to Sales | 5.47 |
| Price to Book Ratio | 2.59 |
| Enterprise Value to Revenue | 6.25 |
| Enterprise Value to EBIT | 31.11 |
| Enterprise Value to Net Income | 39 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.68% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.75%▼ 79.11% |
|---|---|
| Total Invested | $2.30B▼ 97.88% |
| Investors Holding | 441▼ 1791.00% |
ESG Score
No data
About Danaher Corp.
2,020 employees
CEO: Rainer Blair Relevant Senate Committees
While advisory, this committee's non-partisan analysis and 'revenue estimates' are crucial for the development and passage of all tax legislation. Its work directly influences corporate tax structures, capital investment credits, and the overall tax burden on companies like Danaher.
As a large, global corporation, Danaher is profoundly affected by this committee's decisions on taxation and trade policy (tariffs). These policies directly impact corporate valuations, profitability, and international business operations.
This committee directly allocates discretionary federal spending. Its subcommittees determine precise funding for scientific research, healthcare programs (e.g., NIH, VA), environmental agencies (EPA), and defense, all of which are significant customers or influence markets for Danaher's products.
Danaher's significant life sciences, diagnostics, and medical instrument businesses are directly impacted by regulations from the FDA and funding from the NIH, both overseen by this committee. Labor laws also broadly affect its operations.
Danaher is a large company active in mergers and acquisitions. This committee's oversight of antitrust laws and intellectual property (IP) is highly relevant, as M&A approvals and IP protection are critical for Danaher's growth strategy and competitive position.
Danaher manufactures medical instruments and diagnostic tools. This committee's funding decisions for the Department of Veterans Affairs directly impact government healthcare contractors and the demand for medical devices and diagnostics within the VA healthcare system.
Members receive classified briefings on global threats, including biosecurity and emerging health risks. Danaher's life sciences and diagnostics businesses are critical for responding to such threats, creating potential for significant informational asymmetry regarding future government needs or initiatives.
Danaher's 'Environmental & Applied Solutions' segment directly benefits from and is impacted by regulations from the EPA. This committee's decisions on environmental policy and infrastructure drive demand for Danaher's measurement, monitoring, and control instruments.